Intended for healthcare professionals

Papers

Monitoring compliance with the International Code of Marketing of Breastmilk Substitutes in west Africa: multisite cross sectional survey in Togo and Burkina Faso

BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7381.127 (Published 18 January 2003) Cite this as: BMJ 2003;326:127
  1. Victor M Aguayo (vaguayo{at}hkimali.org), regional nutrition and child survival adviser for Africaa,
  2. Jay S Ross, policy coordinator, LINKAGES projectb,
  3. Souleyman Kanon, senior programme officerc,
  4. Andre N Ouedraogo, regional nutrition adviserd
  1. a Helen Keller International, Regional Office for Africa, New York, NY 10010, USA
  2. b Academy for Educational Development, Washington, DC 20009, USA
  3. c International Baby Food Action Network, Regional Office for West Africa, 01 BP 1776 Ouagadougou, Burkina Faso
  4. d World Health Organization, Regional Office for Africa, BE-773 Harare, Zimbabwe
  1. Correspondence to: V M Aguayo
  • Accepted 12 September 2003

Abstract

Objectives: To monitor compliance with the International Code of Marketing of Breastmilk Substitutes in health systems, sales outlets, distribution points, and the news media in Togo and Burkina Faso, west Africa.

Design: Multisite cross sectional survey.

Participants: Staff at 43 health facilities and 66 sales outlets and distribution points, 186 health providers, and 105 mothers of infants aged ≤5 months in 16 cities.

Results: Six (14%) health facilities had received donations of breast milk substitutes. All donations were being given to mothers free of charge. Health providers in five (12%) health facilities had received free samples of breast milk substitutes for purposes other than professional research or evaluation. Health professionals in five (12%) health facilities had received promotional gifts from manufacturers. Promotional materials of commercial breast milk substitutes were found in seven (16%) health facilities. Special displays to market commercial breast milk substitutes were found in 29 (44%) sales and distribution points. Forty commercial breast milk substitutes violated the labelling standards of the code: 21 were manufactured by Danone, 11 by Nestlé, and eight by other national and international manufacturers. Most (148, 90%) health providers had never heard of the code, and 66 mothers (63%) had never received any counselling on breast feeding by their health providers.

Conclusion: In west Africa manufacturers are violating the code of marketing of breast milk substitutes. Comparable levels of code violations are observed with (Burkina Faso) or without (Togo) regulating legislation. Legislation must be accompanied by effective information, training, and monitoring systems to ensure that healthcare providers and manufacturers comply with evidence based practice and the code.

What is already known on this topic

What is already known on this topic All member states of the World Health Assembly have reaffirmed their support for the International Code of Marketing of Breastmilk Substitutes

Violations by manufacturers of breast milk substitutes have been reported in industrialised and developing countries

What this study adds

What this study adds Manufacturers of breast milk substitutes are violating the code in Togo and Burkina Faso

The levels of code violations are similar in a country with (Burkina Faso) and one without (Togo) legislation on the marketing of breast milk substitutes

Legislation must be accompanied by effective information, training, and monitoring systems to ensure compliance with the code

Footnotes

  • Funding This paper is a product of the LINKAGES (Breastfeeding, LAM, Complementary Feeding, and Maternal Nutrition) project. LINKAGES is supported by G/PHN/HN, the US Agency for International Development (USAID) under the terms of Grant No HRN-A-00-97-00007-00. LINKAGES project is managed by the Academy for Educational Development (AED). The opinions expressed in this paper are those of the authors and do not necessarily reflect the views of USAID.

  • Competing interests None declared.

  • Accepted 12 September 2003
View Full Text